CLINCO-MICROBIOLOGICAL PROFILE OF RHINOSINUSITIS IN ADULTS

Autor: Rahul Kawatra, Puneet Maheshwari, Anjali Agarwal, Salwa Salam
Rok vydání: 2023
Předmět:
Zdroj: INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. :66-69
DOI: 10.36106/ijsr/4516832
Popis: Introduction: Rhinosinusitis is the condition in which sinonasal mucosa inside the paranasal sinuses gets inamed and its clinical manifestation is represented by various sinonasal and extra-nasal symptoms. Hence, the present study was planned with an aim to study the clinic-microbial prole of rhinosinusitis in adults. This cross-sectional analytical study included 300 rhi Methodology: nosinusitis patients. Detailed clinical and demographic data were collected. All the patients underwent plain radiography to assess the sinus involvement. Nasal endoscopy was performed in all the cases. During nasal endoscopy, nasal swabs were collected from all the patients. For all the culture positive cases, antibiotic susceptibility assessment was done. The majority of cultures (61.3%) were negative for pathogens. 34% ha Results: d a positive bacterial pathogen culture, while 4.7% had a positive fungal culture. Methicillin-resistant Staphylococcus aureus (MRSA) was the most prevalent gramme-positive isolate (55.9%). Simultaneously, Citrobacter spp. (3.9%) was the most prevalent gramme-negative isolate. Candida spp. accounted for 71.4% of the fourteen positive fungal specimens, while Aspergillus avus accounted for the remaining 28.6%. The majority of patients were only administered antibiotics. Cefoperazone-Sulbactam, Linezolid, Piperacillin-tazobactam, Cefritaxeone, Tobramycin, Meropenem, and Clindamycin exhibited one hundred percent sensitivity. The three most resistant antibiotics used in more than half specimen were Tetracycline (60.7%), Erythromycin (17.4%) and Penicillin (13.7%) respectively. The most prevalent organism causing rhinosinusitis was Conclusion: found to be Staphylococcus aureus and most sensitive antibiotics were Cefoperazone-Sulbactam, Linezolid, Piperacillin-tazobactam, Cefritaxeone, Tobramycin, Meropenem, and Clindamycin.
Databáze: OpenAIRE